Studies have shown that GPSM2 expression decreases CD4 T+ cells in rheumatoid arthritis patients and can act as a promoter of regular T cell migration in healthy individuals (Dang et al., 2021a; Meyer et al., 2021). This evidence concerns the gene CD4 and rheumatoid arthritis.